255 related articles for article (PubMed ID: 8592996)
1. Inducible NorA-mediated multidrug resistance in Staphylococcus aureus.
Kaatz GW; Seo SM
Antimicrob Agents Chemother; 1995 Dec; 39(12):2650-5. PubMed ID: 8592996
[TBL] [Abstract][Full Text] [Related]
2. Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus.
Kaatz GW; Seo SM; Ruble CA
Antimicrob Agents Chemother; 1993 May; 37(5):1086-94. PubMed ID: 8517696
[TBL] [Abstract][Full Text] [Related]
3. Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus.
Aeschlimann JR; Dresser LD; Kaatz GW; Rybak MJ
Antimicrob Agents Chemother; 1999 Feb; 43(2):335-40. PubMed ID: 9925528
[TBL] [Abstract][Full Text] [Related]
4. Introduction of a norA promoter region mutation into the chromosome of a fluoroquinolone-susceptible strain of Staphylococcus aureus using plasmid integration.
Kaatz GW; Seo SM; Foster TJ
Antimicrob Agents Chemother; 1999 Sep; 43(9):2222-4. PubMed ID: 10471568
[TBL] [Abstract][Full Text] [Related]
5. Evidence for the existence of a multidrug efflux transporter distinct from NorA in Staphylococcus aureus.
Kaatz GW; Seo SM; O'Brien L; Wahiduzzaman M; Foster TJ
Antimicrob Agents Chemother; 2000 May; 44(5):1404-6. PubMed ID: 10770791
[TBL] [Abstract][Full Text] [Related]
6. The effects of NorA inhibition on the activities of levofloxacin, ciprofloxacin and norfloxacin against two genetically related strains of Staphylococcus aureus in an in-vitro infection model.
Aeschlimann JR; Kaatz GW; Rybak MJ
J Antimicrob Chemother; 1999 Sep; 44(3):343-9. PubMed ID: 10511401
[TBL] [Abstract][Full Text] [Related]
7. Hydrophilicity of quinolones is not an exclusive factor for decreased activity in efflux-mediated resistant mutants of Staphylococcus aureus.
Takenouchi T; Tabata F; Iwata Y; Hanzawa H; Sugawara M; Ohya S
Antimicrob Agents Chemother; 1996 Aug; 40(8):1835-42. PubMed ID: 8843290
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the nucleotide sequence and expression of norA genes and microbial susceptibility in 21 strains of Staphylococcus aureus.
Noguchi N; Okada H; Narui K; Sasatsu M
Microb Drug Resist; 2004; 10(3):197-203. PubMed ID: 15383162
[TBL] [Abstract][Full Text] [Related]
9. Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome.
Ng EY; Trucksis M; Hooper DC
Antimicrob Agents Chemother; 1994 Jun; 38(6):1345-55. PubMed ID: 8092836
[TBL] [Abstract][Full Text] [Related]
10. Thiazolidinedione and thiazole derivatives potentiate norfloxacin activity against NorA efflux pump over expression in Staphylococcus aureus 1199B strains.
Pereira PS; Lima MDCA; Neto PPM; Oliveira-Tintino CDM; Tintino SR; Menezes IRA; de Oliveira JF; Marchand P; Coutinho HDM; Rodrigues MDD; da Silva TG
Bioorg Med Chem; 2019 Sep; 27(17):3797-3804. PubMed ID: 31320212
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of fluoroquinolone resistance in genetically related strains of Staphylococcus aureus.
Kaatz GW; Seo SM
Antimicrob Agents Chemother; 1997 Dec; 41(12):2733-7. PubMed ID: 9420048
[TBL] [Abstract][Full Text] [Related]
12. Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter.
Neyfakh AA; Borsch CM; Kaatz GW
Antimicrob Agents Chemother; 1993 Jan; 37(1):128-9. PubMed ID: 8431010
[TBL] [Abstract][Full Text] [Related]
13. Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of Staphylococcus aureus.
Kalia NP; Mahajan P; Mehra R; Nargotra A; Sharma JP; Koul S; Khan IA
J Antimicrob Chemother; 2012 Oct; 67(10):2401-8. PubMed ID: 22807321
[TBL] [Abstract][Full Text] [Related]
14. NorA plasmid resistance to fluoroquinolones: role of copy number and norA frameshift mutations.
Sun L; Sreedharan S; Plummer K; Fisher LM
Antimicrob Agents Chemother; 1996 Jul; 40(7):1665-9. PubMed ID: 8807059
[TBL] [Abstract][Full Text] [Related]
15. Efflux-mediated response of Staphylococcus aureus exposed to ethidium bromide.
Couto I; Costa SS; Viveiros M; Martins M; Amaral L
J Antimicrob Chemother; 2008 Sep; 62(3):504-13. PubMed ID: 18511413
[TBL] [Abstract][Full Text] [Related]
16. Aminoguanidine hydrazones (AGH's) as modulators of norfloxacin resistance in Staphylococcus aureus that overexpress NorA efflux pump.
Dantas N; de Aquino TM; de Araújo-Júnior JX; da Silva-Júnior E; Gomes EA; Gomes AAS; Siqueira-Júnior JP; Mendonça Junior FJB
Chem Biol Interact; 2018 Jan; 280():8-14. PubMed ID: 29208359
[TBL] [Abstract][Full Text] [Related]
17. Multiple novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus.
Markham PN; Westhaus E; Klyachko K; Johnson ME; Neyfakh AA
Antimicrob Agents Chemother; 1999 Oct; 43(10):2404-8. PubMed ID: 10508015
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in silico inhibitory effects of synthetic and natural eugenol derivatives against the NorA efflux pump in Staphylococcus aureus.
Muniz DF; Dos Santos Barbosa CR; de Menezes IRA; de Sousa EO; Pereira RLS; Júnior JTC; Pereira PS; de Matos YMLS; da Costa RHS; de Morais Oliveira-Tintino CD; Coutinho HDM; Filho JMB; Ribeiro de Sousa G; Filho JR; Siqueira-Junior JP; Tintino SR
Food Chem; 2021 Feb; 337():127776. PubMed ID: 32777574
[TBL] [Abstract][Full Text] [Related]
19. Efflux pump-mediated quinolone resistance in Staphylococcus aureus strains wild type for gyrA, gyrB, grlA, and norA.
Muñoz-Bellido JL; Alonzo Manzanares M; Martínez Andrés JA; Guttiérrez Zufiaurre MN; Ortiz G; Segovia Hernández M; García-Rodríguez JA
Antimicrob Agents Chemother; 1999 Feb; 43(2):354-6. PubMed ID: 9925531
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of a novel efflux-related multidrug resistance phenotype in Staphylococcus aureus.
Kaatz GW; Moudgal VV; Seo SM
J Antimicrob Chemother; 2002 Dec; 50(6):833-8. PubMed ID: 12461001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
